Second-site NMR screening with a spin-labeled first ligand

[1] CHAO DT, 1998, ANNU REV IMMUNOL, P16395

[2] Affinity NMR [J]. ANALYTICAL CHEMISTRY, 1999, 71 (19) : 669A - 675A

[3] The SHAPES strategy: an NMR-based approach for lead generation in drug discovery [J]. CHEMISTRY & BIOLOGY, 1999, 6 (10): : 755 - 769

[4] NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) : 3144 - 3150

[5] One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (50) : 12257 - 12261

[6] Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (25) : 5818 - 5827

[7] KOSEN PA, 1989, METHOD ENZYMOL, V177, P86

[8] Screening mixtures for biological activity by NMR [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (03): : 705 - 709

[9] NMR screening in drug discovery [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (01) : 54 - 58

[10] X-ray and NMR structure of human Bcl-x(L), an inhibitor of programmed cell death [J]. NATURE, 1996, 381 (6580) : 335 - 341

[1] CHAO DT, 1998, ANNU REV IMMUNOL, P16395

[2] Affinity NMR [J]. ANALYTICAL CHEMISTRY, 1999, 71 (19) : 669A - 675A

[3] The SHAPES strategy: an NMR-based approach for lead generation in drug discovery [J]. CHEMISTRY & BIOLOGY, 1999, 6 (10): : 755 - 769

[4] NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) : 3144 - 3150

[5] One-dimensional relaxation- and diffusion-edited NMR methods for screening compounds that bind to macromolecules [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (50) : 12257 - 12261

[6] Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (25) : 5818 - 5827

[7] KOSEN PA, 1989, METHOD ENZYMOL, V177, P86

[8] Screening mixtures for biological activity by NMR [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 246 (03): : 705 - 709

[9] NMR screening in drug discovery [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (01) : 54 - 58

[10] X-ray and NMR structure of human Bcl-x(L), an inhibitor of programmed cell death [J]. NATURE, 1996, 381 (6580) : 335 - 341